Major lupus drug gets Real-World test in 300 patients
NCT ID NCT07215754
Summary
This study aims to see how well the drug anifrolumab works and how safe it is for people with active systemic lupus erythematosus (SLE) in real-world clinics, not just controlled trials. It will follow 300 adult patients who are already taking or starting the drug for up to five years. The main goals are to see how many patients achieve remission or low disease activity and to track any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Pisa
RECRUITINGPisa, 56100, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.